Utama › Penyakit Paru-paru › New Jersey
Kajian klinikal Penyakit Paru-paru di New Jersey
6 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi di New Jersey.
Bandar di New Jersey
Teks kajian rasmi (Bahasa Inggeris)
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Holy Name Medical Center, Teaneck
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Rutgers, Robert Wood Johnson Medical School, New Brunswick
- Circuit Clinical / Impact Medical Allergy, Asthma & Immunology, Riverdale
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The Valley Hospital, Inc., Paramus
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Cancer Center - Monmouth, Middletown
- Memorial Sloan Kettering Cancer Center - Bergen, Montvale
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT05967689Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- MD Anderson Cooper, Camden
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04614103TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
- Rutgers Cancer Institute, New Brunswick
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 50 hingga 77 · Semua jantina · Dikemas kini 2 Dis 2025 · NCT07165691Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.